Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Anti-Human T-lymphotropic virus type-I antibodies in atomic-bomb survivors.

Matsuo T, Nakashima E, Carter RL, Neriishi K, Mabuchi K, Akiyama M, Shimaoka K, Kinoshita K, Tomonaga M, Ichimaru M.

J Radiat Res. 1995 Mar;36(1):8-16.

2.

Human T-lymphotropic virus type-I infection, antibody titers and cause-specific mortality among atomic-bomb survivors.

Arisawa K, Soda M, Akahoshi M, Matsuo T, Nakashima E, Tomonaga M, Saito H.

Jpn J Cancer Res. 1998 Aug;89(8):797-805.

PMID:
9765614
3.

Human T-cell lymphotropic virus type-1 infection and risk of cancer: 15.4 year longitudinal study among atomic bomb survivors in Nagasaki, Japan.

Arisawa K, Soda M, Akahoshi M, Fujiwara S, Uemura H, Hiyoshi M, Takeda H, Kashino W, Suyama A.

Cancer Sci. 2006 Jun;97(6):535-9.

4.

Epidemic patterns of hepatitis type B virus (HBV) and human T lymphotropic virus type I (HTLV-I) in two ATL-endemic islands in Kyushu, Japan.

Tachibana K, Ito S, Shirahama S, Nagatomo M, Kinoshita K, Tajima K.

Nagoya J Med Sci. 1991 Mar;53(1-4):23-32.

PMID:
1805134
5.

Risk factors for adult T-cell leukemia among carriers of human T-lymphotropic virus type I.

Hisada M, Okayama A, Shioiri S, Spiegelman DL, Stuver SO, Mueller NE.

Blood. 1998 Nov 15;92(10):3557-61.

6.

Prevalence of anti-hepatitis C virus antibody and chronic liver disease among atomic bomb survivors.

Fujiwara S, Kusumi S, Cologne J, Akahoshi M, Kodama K, Yoshizawa H.

Radiat Res. 2000 Jul;154(1):12-9.

PMID:
10856960
7.

Autoantibodies and immunoglobulins in atomic bomb survivors with human T-lymphotropic virus type I.

Ohishi K, Shibata Y, Nakamura T, Tsujihata M, Akahoshi M, Matsuo T, Tomonaga M, Nagataki S, Shimaoka K.

Intern Med. 1996 Aug;35(8):624-8.

8.

Cohort study of hepatotropic virus and human T lymphotropic virus type-I infections in an area endemic for adult T cell leukemia.

Kamihira S, Momita S, Ikeda S, Yamada Y, Sohda H, Atogami S, Tomonaga M, Kinoshita K, Toriya K, Furukawa R.

Jpn J Med. 1991 Nov-Dec;30(6):492-7.

9.

Antibody to p40tax protein of human T cell leukemia virus 1 and infectivity.

Kashiwagi S, Kajiyama W, Hayashi J, Noguchi A, Nakashima K, Nomura H, Ikematsu H, Sawada T, Kida S, Koide A.

J Infect Dis. 1990 Mar;161(3):426-9.

PMID:
2313123
10.

Prevalence of human T-cell leukemia virus type 1 (HTLV-I) in general inhabitants in non-adult T-cell leukemia (ATL)-endemic Hokkaido, Japan.

Kwon KW, Yano M, Sekiguchi S, Iwanaga M, Fujiwara S, Oikawa O, Sugiura M, Imai S, Osato T.

In Vivo. 1994 Nov-Dec;8(6):1011-4.

PMID:
7772728
11.

Prevalence of hepatitis B virus infection among atomic bomb survivors.

Fujiwara S, Sharp GB, Cologne JB, Kusumi S, Akahoshi M, Kodama K, Suzuki G, Yoshizawa H.

Radiat Res. 2003 Jun;159(6):780-6.

PMID:
12751961
12.

Prevalence of human T-cell leukemia virus type 1 (HTLV-I) in adult T-cell leukemia (ATL) in non-ATL-endemic Hokkaido of Japan.

Iwanaga M, Takada K, Fujiwara S, Oikawa O, Sugiura M, Imai S, Osato T, Mikuni C, Maekawa I, Miyazaki T, et al.

In Vivo. 1994 Nov-Dec;8(6):1007-10.

PMID:
7772727
13.

Salivary gland tumors among atomic bomb survivors, 1950-1987.

Saku T, Hayashi Y, Takahara O, Matsuura H, Tokunaga M, Tokunaga M, Tokuoka S, Soda M, Mabuchi K, Land CE.

Cancer. 1997 Apr 15;79(8):1465-75.

PMID:
9118025
14.

A nested case-control study of risk factors for adult T-cell leukemia/lymphoma among human T-cell lymphotropic virus type-I carriers in Japan.

Arisaw K, Katamine S, Kamihira S, Kurokawa K, Sawada T, Soda M, Doi H, Saito H, Shirahama S.

Cancer Causes Control. 2002 Sep;13(7):657-63.

PMID:
12296513
15.

Prevalence of antibody to human T-cell lymphotropic virus type I in Okinawa, Japan, after an interval of 9 years.

Morofuji-Hirata M, Kajiyama W, Nakashima K, Noguchi A, Hayashi J, Kashiwagi S.

Am J Epidemiol. 1993 Jan 1;137(1):43-8.

PMID:
8434571
16.

Autoantibodies and immunoglobulins among atomic bomb survivors.

Fujiwara S, Carter RL, Akiyama M, Akahoshi M, Kodama K, Shimaoka K, Yamakido M.

Radiat Res. 1994 Jan;137(1):89-95.

PMID:
8265792
17.

Human T-lymphotropic virus type I (HTLV-I) and adult T-cell leukemia (ATL) are endemic to southwestern Japan.

Miyazaki K, Yamaguchi K, Takatsuki K, Fujisaki S, Okamura H.

Gynecol Oncol. 1990 May;37(2):306. No abstract available.

PMID:
2344977
18.

Effects of radiation on the longitudinal trends of total serum cholesterol levels in the atomic bomb survivors.

Wong FL, Yamada M, Sasaki H, Kodama K, Hosoda Y.

Radiat Res. 1999 Jun;151(6):736-46.

PMID:
10360794
19.

Decline in the positive rate of human T-lymphotropic virus type-1 (HTLV-1) antibodies among blood donors in Nagasaki.

Chiyoda S, Kinoshita K, Egawa S, Inoue J, Watanabe K, Ifuku M.

Intern Med. 2001 Jan;40(1):14-7.

20.

[Epidemiology of HTLV-I carriers in Hirado Island and virological and immunological investigation of HTLV-I associated pulmonary disease].

Kohno S, Higashiyama Y, Mukae H, Morikawa N, Kadota J, Koga H, Hara K, Ikeda S, Tomonaga M, Katamine S, et al.

Nihon Kyobu Shikkan Gakkai Zasshi. 1992 May;30(5):763-9. Japanese.

PMID:
1630038

Supplemental Content

Support Center